BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11233545)

  • 1. 99Tc(m)-MAG3: problems with radiochemical purity testing.
    Ensing GJ; Knight HH
    Nucl Med Commun; 2001 Jan; 22(1):114-5. PubMed ID: 11233545
    [No Abstract]   [Full Text] [Related]  

  • 2. Simplified method for determining the radiochemical purity of 99mTc-MAG3.
    Seetharaman S; Ballinger JR; Sosabowski MH
    J Nucl Med Technol; 2006 Sep; 34(3):179-83. PubMed ID: 16951288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of 99Tcm-MAG3: no confirmation that sodium chloride injections from plastic containers affect radiochemical purity.
    Millar AM; O'Brien LM
    Nucl Med Commun; 1998 May; 19(5):475-7. PubMed ID: 9853337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation of lyophilized single vial kit of N-N-Ethylene-L-Dicysteine (EC) for labeling with
    Afshan A; Sohaib M; Jehangir M
    Pak J Pharm Sci; 2017 Jul; 30(4):1289-1295. PubMed ID: 29039327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 99Tc(m)-MAG3: problems with radiochemical purity.
    Vinberg N
    Nucl Med Commun; 2000 Sep; 21(9):869-70. PubMed ID: 11065162
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of SepPak and high-performance liquid chromatography as techniques for measuring the radiochemical purity of 99mTc-MAG3.
    Millar AM; Hesslewood SR
    Nucl Med Commun; 2004 Oct; 25(10):1049-51. PubMed ID: 15381873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of solvent flow rate in mini-column testing of 99mTc-mertiatide.
    Ponto JA
    J Nucl Med Technol; 2005 Dec; 33(4):232-3. PubMed ID: 16322124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preparation and quality control of 99mTc labeled MDR1 oligonucleotide DNAs].
    Fan C; Hnatowich DJ
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Jun; 25(3):712-5. PubMed ID: 18693462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing different storage conditions for (99m)Tc-MAG3 kit: can hot fractioning reduce the cost per unit dose?
    Kiratli PO; Salanci BV
    J Nucl Med Technol; 2003 Jun; 31(2):74-5. PubMed ID: 12777456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of 99m Tc-MAG3: the effect on radiochemical purity of using sodium chloride injection from plastic ampoules that have been exposed to light.
    Beattie LA; O'Brien LM; Waight CC; Homer NZ; Andrew R; Millar AM
    Nucl Med Commun; 2008 Jul; 29(7):649-53. PubMed ID: 18528188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality control of instant kit 99mTc-mercapto acetyl triglycine with inter- and intra-operator measurements.
    Bozkurt MF; Kiratli PO; Konyali D; Metin F
    Hell J Nucl Med; 2009; 12(1):59-62. PubMed ID: 19330186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of generator eluate age on the radiochemical purity of fractionated 99Tcm-MAG3.
    Hung JC; Thorson LM
    Nucl Med Commun; 1995 Mar; 16(3):157-60. PubMed ID: 7770239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of alternative reconstitution procedures on the labelling efficiency and in vitro stability of 99Tcm-labelled radiopharmaceuticals.
    Bogsrud TV; Chen MN; Herold TJ; Mahoney DW; Hung JC
    Nucl Med Commun; 1999 Jan; 20(1):61-5. PubMed ID: 9949414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3'-99mTc-labeling and biodistribution of a CAPL antisense oligodeoxynucleotide.
    Hjelstuen OK; Tønnesen HH; Bremer PO; Verbruggen AM
    Nucl Med Biol; 1998 Oct; 25(7):651-7. PubMed ID: 9804046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of 99mTc/99Tc-MAG3-biotin conjugates for antibody pretargeting strategies.
    van Gog FB; Visser GW; Gowrising RW; Snow GB; van Dongen GA
    Nucl Med Biol; 1998 Oct; 25(7):611-9. PubMed ID: 9804042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An investigation of factors that might influence the radiochemical purity and stability of 99mTc-MAG3.
    Millar AM; O'Brien LM
    Eur J Nucl Med; 1990; 16(8-10):615-9. PubMed ID: 2143474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma clearance of 99Tc(m)-MAG3: accuracy of five single-sample methods.
    Piepsz A; De Sadeleer C; Ham HR
    Nucl Med Commun; 2000 Dec; 21(12):1160-2. PubMed ID: 11200021
    [No Abstract]   [Full Text] [Related]  

  • 18. [A comparison on radiochemical behavior and biological property of antisense oligonucleotide labeled with technetium-99m by two methods: NHS-MAG3 versus SHNHP].
    Li Y; Tan T; Zheng J; Zhang C
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Aug; 25(4):889-93, 902. PubMed ID: 18788302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 99Tcm-MAG3: problems with radiochemical purity testing.
    Murray T; McKellar K; Owens J; Watson WS; Hilditch TE; Elliott AT
    Nucl Med Commun; 2000 Jan; 21(1):71-5. PubMed ID: 10717905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The radiolabeling property of oligonucleotide with 99mTc using NHS-MAG3 as a chelator].
    Zhang C; Tan TZ; Kuang AR; Li YC; Zheng JG; Pan WM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Mar; 35(2):169-71. PubMed ID: 15071906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.